To investigate the regulation of the actomyosin crossbridge cycle in cardiac muscles, the effects of ATP, ADP, Pi, and creatine phosphate (CP) on the rate of force redevelopment (ktr) were measured. We report that CP is a primary determinant in controlling the actomyosin crossbridge cycling kinetics of cardiac muscles, because a reduction of CP from 25 to 2.5 mmol/L decreased ktr by 51% despite the presence of 5 mmol/L MgATP. The effects of CP on ktr were not a reflection of reduced ATP or accumulated ADP, because lowering ATP to 1 mmol/L or increasing ADP to 1 mmol/L did not significantly decrease ktr. Therefore, the effect of CP on the actomyosin crossbridge cycle is proposed to occur through a functional link between ADP release from myosin and its rephosphorylation by CP-creatine kinase to regenerate ATP. In activated fibers, the functional link influenced the kinetics of activated crossbridges without affecting the aggregate number of force-generating crossbridges. This was demonstrated by the ability of CP to affect ktr in maximally and submaximally activated fibers without altering the force per cross-sectional area. The data also confirm the important contribution of strong binding crossbridges to cardiac muscle activation, likely mediated by cooperative recruitment of adjacent crossbridges to maximize force redevelopment against external load. These data provide additional insight into the role of CP during pathophysiological conditions such as ischemia, suggesting that decreased CP may serve as a primary determinant in the observed decline of dP/dt. (Circ Res. 2003;93:54-60.)
F orce development in striated muscles is a cooperative process of actomyosin (AM) crossbridge cycling and depends on the availability of ATP. The conversion of chemical energy from ATP hydrolysis to mechanical energy supports the transitions between individual states of the AM ATPase during muscle contraction. 1 Therefore, the balance between ATP and its hydrolysis byproducts is a primary determinant for the kinetics of the AM crossbridge cycle. However, the in vivo concentrations of ATP under normal and pathophysiological conditions remain above the K m for AM's ability to generate maximal force or maintain its maximum unloaded velocity of shortening (V max ). In fact, the half-maximal ATP concentration required to support the AM ATPase is Ϸ150 mol/L or less. 2, 3 This is well below the observed concentrations of ATP in the myocardium under normal or pathophysiological conditions. 4 -8 These data raise the question of how in vivo ATP concentration affects the kinetics of the AM crossbridge cycle, indirectly suggesting that ATP is not the limiting factor. Alternatively, ADP accumulation may accompany the reduction in ATP, resulting in the decline of cardiac muscle contractility by slowing ADP release from the rate-limiting, ADP-bound state of AM (AM · ADP). 9, 10 The balance between ATP and ADP concentrations is hypothesized to be a primary factor complicating contractility during cardiomyopathies, 11 aortic valve disease, 12 and coronary artery disease. 13 Although ADP is believed to exert a dominant effect in slowing contractility, the magnitude of ADP accumulation is modest, remaining as low as 27 mol/L with 30 minutes of low-flow ischemia. 4, 5, 7, 14 In myocytes, excessive accumulation of ADP is prevented in part by creatine kinase (CK) catalyzing the rephosphorylation of ADP to ATP using creatine phosphate (CP) as a substrate. This implicates CP as an important factor in maintaining ATP while moderating the build up of ADP concentrations in muscle, consistent with the proposal that the CK reaction is involved in high-energy phosphoryl homeostasis. 15, 16 However, function of CK in cells may be more complex, indirectly influencing the kinetics of other ATPases as well as the rate of glycolysis and oxidative phosphorylation. 17, 18 The importance of CK in cardiac muscle contractility is indirectly supported by the large changes in CP concentration observed during ischemia. For example, Cave et al 4 demonstrated a decrease in CP from 18.5 to 8.9 mmol/L (52%) within 10 minutes of low-flow ischemia, compared with a 25% decrease in ATP (10.8 to 8.1 mmol/L) during the same time frame. These observed changes in CP concentration are consistently rapid in onset and greater in magnitude than the decline of ATP. 4, 5 Therefore, it is of interest to determine the contribution of CP to contractility beyond the assumption that it serves as a substrate to maintain intracellular ATP concentration.
Using known in vivo substrate concentrations as a guideline, our experiments focused on the factors controlling force redevelopment in cardiac muscles. Experiments testing the rate of tension redevelopment (ktr 19 ) and V max of trabeculae under various substrate conditions were used to monitor overall crossbridge cycling under loaded (ktr) and unloaded (V max ) conditions. The results suggest that the CP-CK reaction is functionally linked to the AM crossbridge cycle and may serve as a primary substrate that limits force redevelopment under load. We provide additional evidence that ADP release from myosin is the step of the crossbridge cycle coupled with the CK reaction.
Materials and Methods

Trabecula Preparation
Mice were purchased from Jackson Labs (Bar Harbor, Maine) and their care and use were in accordance with the guidelines of the American Physiological Society using a protocol approved by the Institutional Animal Care and Use Committee of Case Western Reserve University. Mice were killed by CO 2 asphyxiation, the heart was rapidly removed and placed in cold Ca 2ϩ -free physiological saline solution (in mmol/L, NaCl 140, KCl 4.7, Na 2 HPO 4 0.3, MOPS 2, EGTA 0.5, EDTA 0.2, MgCl 2 1.2, and glucose 5.6, pH adjusted to 7.4 with 1 N KOH), 20 and the left ventricle was exposed. Trabeculae were immediately excised, and their ends were fixed with a small volume (Ͻ1 L) of 1% glutaraldehyde in 50% glycerol, 21 followed by attachment of aluminum T-clips to the ends. Trabeculae were skinned for 45 minutes at 4°C in pCa9 (1 nmol/L free Ca 2ϩ ) solution containing 1% vol/vol Triton X-100 (in mmol/L, MgATP 5 [free], EGTA 5, potassium methane sulfonate 25, MgCl 2 6.9 [1 mmol/L free Mg 2ϩ ], CP 25, BES 25, and glutathione 2, 1% vol/vol Triton X-100, pH 7). After skinning, the tissues were transferred to pCa9 relaxing solution (1 nmol/L free Ca 2ϩ , 5 mmol/L MgATP [free], 10 mmol/L EGTA, 56.5 mmol/L potassium methane sulfonate, 7.2 mmol/L MgCl 2 [1 mmol/L free Mg 2ϩ ], 25 mmol/L CP, and 25 mmol/L BES, pH 7) and mounted on the stage of a computer-controlled mechanics workstation. One end of the tissue was hooked to a length controller (Model 308B, Aurora Scientific) and the other to a force transducer (Akers AE801). The trabeculae were stretched to an average sarcomere length of Ϸ2.2 m, as determined by laser diffraction, 22 and the length of the muscle was recorded as Lo. Trabeculae were activated by a pCa4 solution (in mmol/L, free Ca 2ϩ 0.1, MgATP 5 [free], EGTA 10, potassium methane sulfonate 35.8, MgCl 2 7.0 [1 mmol/L free Mg 2ϩ ], CP 25, and BES 25, pH 7). When specifically indicated, CK (20 U/mL; Sigma Chemicals) was added to the solutions before experiments. Temperature during experiments was controlled to 15Ϯ0.1°C. Solutions of varying CP, MgATP, MgADP, Pi, or Ca 2ϩ were mixed according to a program calculating the amount of stock solutions required for a given set of free ion concentrations at 15°C and an ionic strength of 200 mmol/L. 20 Binding constants of the species present were corrected for temperature and ionic strength. For experiments testing the effect of CP at submaximal Ca 2ϩ concentrations, a Ca 2ϩ electrode (Orion) was used to ensure reproducible Ca 2ϩ concentrations across solutions. Force generated from the fibers was normalized to the maximum force per cross-section (F max ) by measuring the width and thickness of the tissues and assuming an elliptical cross-section. In experiments testing ktr during submaximal activation (pCa5.4), tissues were activated by saturating Ca 2ϩ (pCa4) at completion of the measurements to determine the relative force produced at pCa5.4 versus pCa4.
Mechanical Measurements
Mechanical measurements predicated on controlling the force or muscle length were programmed in steps into the 600A Digital Controller (Aurora Scientific). Experiments controlling the length of the preparation used a feedback loop based on muscle, not sarcomere length. The software was interfaced to the length controller and force transducer by a 16-bit A/D:D/A, 200-kHz interface. Maximum sampling frequency of recording was 10 kHz.
Rate of Force Redevelopment
Experiments were done as described 19 with an adjustment to maximize crossbridge detachment in cardiac muscle (M. Regnier, University of Washington, Seattle, Wash, personal communication, 2001). The protocol involved decreasing Lo by 20% during a 5-ms ramp, a subsequent step change in length to 1.05 Lo for 2 ms followed by restoration of length to Lo. With this protocol, force routinely fell to and redeveloped from zero. ktr was determined by single exponential fits to the force redevelopment over time. Data are presented as averageϮSEM.
Maximum Unloaded Shortening Velocity
V max was determined by a series of isotonic contractions between 3% and 80% of F max . Forces routinely fell to the set isotonic level within 3 to 5 ms. The velocity of shortening for each isotonic contraction was determined from the slope of a linear fit to the length trace between 20 and 25 ms of the protocol. Velocities were normalized to muscle length (ML) per second, plotted as a function of force, and fit by the Hill equation 2,23 to determine the extrapolated shortening velocity at zero force. Data are presented as averageϮSEM.
Results
Initial experiments demonstrated that ktr was largely insensitive to MgATP concentration (1 to 10 mmol/L) in the presence of 25 mmol/L CP, resulting in similar rates at all ATP concentrations tested (average 24.6Ϯ1.4 s Ϫ1 across MgATP concentrations; Table 1 ). In fact, the 1 mmol/L MgATP tested is well below concentrations observed with extended periods of ischemia (5.3 mmol/L 4 ), increased cardiac work (7.5 mmol/L 14 ), or even myocardial infarction (3.7 mol/g wet weight or Ϸ4.63 mmol/L, assuming 80% of muscle wet weight is water 5 ). This suggests that physiological concentrations of MgATP are unlikely to play a role in defining ktr.
We next determined the effect of CP on the rate of force redevelopment. In the presence of 5 mmol/L MgATP, changes in CP concentration under saturating Ca 2ϩ concentrations (pCa4) were not expected to affect ktr because of sufficient MgATP supply. However, decreasing CP from 25 to 2.5 mmol/L at pCa4 resulted in a 51% decrease in ktr (23.9 
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Creatine Kinase Affects the Crossbridge Cycle to 11.6 s Ϫ1 ; Figure 1 ). This effect was also observed in fibers activated with submaximal Ca 2ϩ concentrations. In the presence of 25 mmol/L CP, ktr decreased by 30.5% when the free Ca 2ϩ concentration was decreased from pCa4 to pCa5.4. This was accompanied by a 20.2% decrease in F max (Figure 2 ). Decreasing CP concentration additionally from 25 to 10 mmol/L at pCa5.4 caused a relative 18% drop in ktr, similar to the 20% decline observed when CP was decreased from 25 to 10 mmol/L CP at pCa4 (Table 1 ). These data suggest that the relationship between ktr and CP concentration is similar in submaximally and maximally Ca 2ϩ -activated cardiac muscle fibers. An alternate explanation for the observed decline of ktr with decreasing CP would be MgADP accumulation from insufficient rephosphorylation by CK. Therefore, the effect of CP concentration on ktr was tested with the addition of 1 mmol/L total MgADP (Figure 1 ). After the addition of 1 mmol/L MgADP, F max increased from 110Ϯ14 mN/mm 2 (nϭ8) to 152Ϯ21 mN/mm 2 (nϭ7; Figure 3 ). This observation is consistent with the concentration of MgADP rising locally at the crossbridges, in turn increasing the population of the strongly bound, AM · ADP state to account for the increase in F max . 10, 24 However, at all CP concentrations tested, the additional 1 mmol/L MgADP did not slow ktr but rather resulted in small increases ( Figure 1 ). This suggests that the decline in ktr attributable to decreasing CP was not caused by MgADP accumulation. Nonetheless, it remained possible that the loss of myofibrillar CK activity after Triton X-100 permeabilization additionally compromised the ATP:ADP balance. Using a modification of a published protocol, 25 the activity of the myofibrillar CK fraction in the skinned cardiac muscle fibers was measured to be 6.7Ϯ0.1 U/min per mg protein (nϭ3, data not shown), in agreement with previously published data. 26 These results did not indicate irreversible loss of myofibrillar CK enzyme during tissue preparation, implying that additional CK in the fibers would not effectuate any change in contractility. This was confirmed by experiments testing ktr in the presence or absence of additional CK (20 U/mL). At pCa4 with 10 or 25 mmol/L CP, the addition of 20 U/mL CK did not change the measured ktr values (Figure 4 ), suggesting that the endogenous myofibrillar CK activity in the fibers was not a limiting factor for the experiments.
Because CP was shown to influence contractility under load, we also tested the effect of CP on unloaded contractility. Experiments measured the V max of fibers under different CP concentrations, either in the presence or absence of 1 mmol/L MgADP. For muscles activated at pCa4 with 5 mmol/L MgATP and 25 mmol/L CP, V max was 4.9Ϯ0.3 ML/s (nϭ8, Figure 3 ). With the addition of 1 mmol/L MgADP, V max increased to 6.4Ϯ0.7 ML/s (nϭ7, Pϭ0.03). By contrast, decreasing CP from 25 to 5 mmol/L did not have a significant effect on V max (4.3Ϯ0.3 ML/s, nϭ7, Pϭ0.09), despite a 37.7% decrease in ktr under those conditions. Similar to previous reports, 27 the decrease of CP from 25 to 5 mmol/L did not significantly change F max .
To determine the crossbridge step coupled with CK activity, ktr experiments were also done in the presence of varying Pi. In agreement with previously published data, 28, 29 we observed an Ϸ3 fold increase in ktr with increasing Pi in the presence of 25 mmol/L CP (23.9Ϯ0.4 to 62.3Ϯ1.0 s Ϫ1 , Figure  5 ). The changes in ktr were accompanied by decreases in F max (Table 2) , consistent with a low or no force producing Force redevelopment under load for mouse trabeculae at different CP concentrations. A, Typical force response after the length release-restretch procedure to determine the rate of force redevelopment. The experiment was done in the presence of 5 mmol/L MgATP and 25 mmol/L CP. B, Relationship between ktr and CP concentration in the absence (ⅷ) and presence (⅙) of 1 mmol/L MgADP. The addition of 1 mmol/L MgADP did not slow ktr but rather increased ktr at all CP concentrations tested. Data points are averageϮSEM from a minimum 3 trabeculae with a minimum of 6 measurements from each fiber.
AM ADP Pi state, rapidly isomerizing to a force producing AM ADP Pi* step before Pi release. 28 -30 Additional Pi titrations were also done without CP. Although the effect on F max was unchanged (Table 2) , ktr no longer showed a dosedependent response to Pi, with rates remaining between 13.2 and 15.0 s Ϫ1 ( Figure 5 ). This strongly suggests that the increase in ktr with increasing Pi requires CP.
Discussion
In this study, we provide evidence that CP utilization by CK is functionally linked and tightly coupled with the AM crossbridge cycle, exerting control on the kinetics of the crossbridge cycle despite adequate, physiological ATP concentrations. We found that ktr in cardiac muscle is strongly dependent on CP concentration, resulting in a decline of ktr with declining CP during both maximal and submaximal Ca 2ϩ -activated contractions (Figures 1 and 2 ; Table 1 ). Our results also suggest that the CP-CK system regulates the kinetics of the activated AM crossbridges without affecting the aggregate number of active crossbridges. This was supported by data demonstrating that a significant change in ktr can be observed without commensurate changes in F max . For example, when CP was decreased from 25 to 10 mmol/L at pCa5.4, ktr decreased by 18% despite only a 4% decrease in F max (Figure 2 ). This was also true at saturating Ca 2ϩ (pCa4), because a decrease of CP from 25 to 5 mmol/L decreased ktr by 38% ( Figure 1; Table 1 ) without a significant decrease in F max (Figure 3) .
To address the hypothesis that there is a functional link between the CP-CK reaction and the AM cycle, three substrate variables known to contribute to crossbridge kinetics were varied. First of all, declining ktr with declining CP may be indicative of a decrease in ATP, suggesting that CK was unable to maintain adequate ATP concentrations and thereby slowed the rate of crossbridge cycling. However, changes of MgATP concentration within the physiological range did not affect force redevelopment. This was demonstrated by the relative insensitivity of ktr to concentrations of MgATP ranging from 1 to 10 mmol/L ( Table 1 ) and additionally supported by published data demonstrating an insensitivity of ktr, 29 F max , 2,3 and V max 2 to MgATP concentrations Ͼ1 mmol/L. In healthy individuals, mean total ATP values in the heart may range between 7.2 and 7.7 mol/g wet weight.
Assuming water content of 80% per gram of wet muscle weight, this calculates to an ATP concentration of Ϸ9 mmol/ L. 6, 31 Models of myocardial infarction have shown a 42% decrease in ATP content from 6.4 to 3.7 mol/g wet weight, 5 or from 8 to 4.6 mmol/L. Therefore, ATP concentrations even after infarction remain well above the 1 mmol/L MgATP tested in our experiments, strongly suggesting that variations in ATP would not be a limiting factor in the decline of contractility when CP concentration decreases during infarction.
To address the possible influence of ADP in our experiments, the effect of CP on ktr was measured in the presence of 1 mmol/L MgADP. The chosen ADP concentration is Ϸ6to 10-fold above known levels of intracellular total ADP during ischemia or increased cardiac 5, 7, 14 and Ϸ3 to 4 times the estimated K i for inhibition of fiber velocity by MgADP. 10 The addition of MgADP resulted in an expected rise in F max (Figure 3 ), 10, 24 suggesting that MgADP reached the contractile apparatus and increased the population of strong binding AM · ADP crossbridges. Interestingly, 1 mmol/L MgADP accelerated ktr at various CP concentrations (Figure 1) , possibly through cooperative activation of adjacent thin filament regulatory units by strong binding crossbridges in the AM · ADP state. This raised the possibility that the observed acceleration in the kinetics of the crossbridge cycle reflected by ktr may also result in an increase of V max . In agreement with this prediction, the addition of 1 mmol/L MgADP accelerated V max (Figure 3) . Coupled with the measured concentrations of total ADP during ischemia or myocardial infarction, the data suggest that the increase of ADP under physiological or pathophysiological conditions in cardiac muscles would not slow the AM cycle. 32 Therefore, the slowing of ktr with decreased CP is not reasonably explained by a rise in ADP. However, it remained possible that Triton X-100 skinning of mouse myocardium resulted in complete removal of the endogenous myofibrillar CK and therefore reduced the overall activity of the CP-CK reaction. Although we observed that myofibrillar CK activity was retained after skinning, results of experiments measuring ktr in the presence or absence of an additional 20 U/mL CK were not different ( Figure 4 ). This suggests that the CK enzyme content was not a rate-limiting factor in the experiments.
The improvement of contractility (ktr and V max ) with the addition of 1 mmol/L MgADP was likely through cooperative recruitment of adjacent crossbridges, in agreement with previous experiments using either strong binding, N-ethylmaleimide-modified myosin S1 subfragments, or alternate myosin substrates (dATP 33, 34 ). The data here support the findings that maximal cardiac muscle activation depends not only on Ca 2ϩ but also on myosin crossbridge attachment. 33, 34 Although the ADP results suggested that strong binding crossbridges may serve to activate adjacent regulatory units, this effect likely has an optimal window whereby additional increases in ADP concentrations (or the ADP:ATP ratio) would be inhibitory to the rate of the AM crossbridge cycle. Higher ADP concentrations competing with ATP for AM binding would thereby limit crossbridge detachment. 24 This is supported by our observations that in the presence of 5 mmol/L MgATP, increasing ADP concentrations from a nominal level to 2 mmol/L or greater decreases ktr by at least 19% or more (data not shown). This agrees with experiments by Tesi et al 28 demonstrating a 23% decrease in ktr when MgADP was increased to 3 mmol/L.
With the demonstration of the functional link between CP consumption and the AM crossbridge cycle, it remains of interest to determine the crossbridge steps involved. The two steps of the AM cycle that share common substrates with CK are the release of ADP from myosin and the reintroduction of ATP to myosin ( Figure 6 ). Using CK knockout mice, Ventura-Clapier et al 35 demonstrated that rigor crossbridges were more effectively detached with active CP-CK and ATP versus ATP alone. It was therefore suggested that ATP from CP-CK is the preferential substrate for detachment of myosin from the AM state. This would be consistent with the assumption that all crossbridges resulting from ATP depletion are in the AM state. However, Martin and Barsotti 36 demonstrated that crossbridges in cardiac muscle formed by ATP depletion include a significant population of AM · ADP crossbridges in addition to the expected, rigor AM population. Therefore, to relax muscles from the rigor state, the AM · ADP must move to the AM state before ATP-induced crossbridge detachment. Therefore, the ability of CP-CK to effectively reduce experimental rigor does not require CKderived ATP to serve as a preferential myosin substrate. Rather, CK seems to accelerate the release of ADP from AM · ADP to establish the AM state for subsequent ATP binding and myosin detachment ( Figure 6 ). This hypothesis would be in agreement with the increase in relaxation times for CK knockout mice being a reflection of impaired ADP release from the AM · ADP state of the crossbridge cycle. 37 This hypothesis is also in agreement with biochemical data suggesting that ADP release from AM · ADP, not ATP binding to AM, is the rate-limiting step of the crossbridge cycle. 9 These data support a functional link between CP-CK and the AM · ADP state of the crossbridge cycle, facilitating ADP release from AM · ADP to decrease the relative attachment time of this strong binding state. However, the observed effect of Pi on ktr suggested that AM · ADP was not the sole state coupled with CK activity. It is known that exogenous Pi leads to a shift in the distribution of crossbridges from strong-binding, high-force producing states (AM · ADP, AM) to weak binding states (AM · ADP · Pi) in equilibrium with detached states (AϩM · ADP · Pi). 1, 28, 38 In our experiments in the presence of 25 mmol/L CP, increasing Pi increased ktr, consistent with a rapid AM · ADP · Pi to AM · ADP · Pi* isomerization. 28, 29 Surprisingly, the ability of exogenous Pi to increase ktr was abolished when CP was omitted ( Figure 5 ), suggesting that a crossbridge step involved in the Pi-dependent increase of ktr was rate-limited by CP. If the detached AϩM · ADP · Pi state is followed by Pi release from myosin, then the subsequent ADP release from detached myosin may also depend on the CP-CK reaction. This is indirectly supported by the expectation that the AM · ADP state would be sparsely populated under high Pi, explaining the observed decrease of F max and therefore necessitating involvement of the detached M · ADP state. Therefore, we propose that ADP release either from the bound AM · ADP or the detached M · ADP states are coupled with CK activity.
In myocytes, CK is colocalized to the A band of sarcomeres in proximity to myosin. 35, 39, 40 The localization of CK may have additional implications during myocardial ischemia, because the enzyme has been found to diffuse away from the A band toward the I band, possibly compromising the relationship between CK activity and the AM crossbridge cycle. 41, 42 Furthermore, the clinical importance of CP-CK is exemplified by the observed decrease in CK enzyme activity and CP content in failing versus nonfailing hearts. 12, 13, 43, 44 This is in addition to the compromise of the CP:ATP ratio in heart failure, which serves as a predictor of cardiovascular mortality. 11, 45 The experiments described herein support the hypothesis that a change in CK activity, either through changes in substrate concentration or changes in the specific activity of CK, will affect the crossbridge cycle. Therefore, the demonstrated functional link between CK activity and the AM crossbridge cycle may have additional implications for the observed deficits in cardiac muscle contractility under pathophysiological conditions.
